Quantcast
Last updated on April 17, 2014 at 8:41 EDT

Latest Cenetron Diagnostics Stories

2008-09-09 06:00:39

Asuragen, Inc., announces that it has granted Focus Diagnostics, Inc., the infectious disease diagnostics company of Quest Diagnostics, non-exclusive worldwide rights to incorporate Armored RNA(R) technology into its in vitro molecular diagnostics products. Under the terms of the Agreement, Asuragen will develop and supply reagents for Focus Diagnostics in Asuragen's QSR-compliant manufacturing facility. Additional terms were not disclosed. Armored RNA(R) is a technology jointly invented...